Re:Ben Goldacre: Here’s the foreword to my new book, Bad Pharma
by tocomment on Tuesday September 25, 2012 @09:28AM
(#4570188)
That's really interesting. Thanks. So in theory a startup might be able to get that 20 million figure down to 5 million if they're lean?
[ Parent
| on HN ]
Re:Ben Goldacre: Here’s the foreword to my new book, Bad Pharma
by Alex3917 on Tuesday September 25, 2012 @12:15PM
(#4571131)
"So in theory a startup might be able to get that 20 million figure down to 5 million if they're lean?"
Not likely, MAPS is already as lean as you can get. And they have a big advantage since there have already been dozens or hundreds of previous studies done on MDMA to establish safety.